NDC 59267-1055

Pfizer-BioNTech Covid-19 Vaccine

Bnt162b2

Pfizer-BioNTech Covid-19 Vaccine is a Intramuscular Injection, Suspension in the Vaccine category. It is labeled and distributed by Pfizer Manufacturing Belgium Nv. The primary component is Tozinameran.

Product ID59267-1055_073f91e1-999c-4e03-a3fa-17fe941f2313
NDC59267-1055
Product TypeVaccine
Proprietary NamePfizer-BioNTech Covid-19 Vaccine
Generic NameBnt162b2
Dosage FormInjection, Suspension
Route of AdministrationINTRAMUSCULAR
Marketing Start Date2021-10-30
Marketing CategoryEMERGENCY USE AUTHORIZATION /
Labeler NamePfizer Manufacturing Belgium NV
Substance NameTOZINAMERAN
Active Ingredient Strength130 ug/2.6mL
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 59267-1055-4

10 VIAL, GLASS in 1 CARTON (59267-1055-4) > 2.6 mL in 1 VIAL, GLASS (59267-1055-1)
Marketing Start Date2021-10-30
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Pfizer-BioNTech Covid-19 Vaccine" or generic name "Bnt162b2"

NDCBrand NameGeneric Name
59267-0078Pfizer-BioNTech Covid-19 VaccineBNT162b2
59267-1000Pfizer-BioNTech Covid-19 VaccineRNA ingredient BNT-162B2
59267-1025Pfizer-BioNTech Covid-19 VaccineBNT162b2

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.